You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

XDR-TB

Showing 1 - 25 of 956
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triage Test for All Oral DR-TB Regimen (TRiAD Study)

Recruiting
  • Drug Resistant Tuberculosis
  • +3 more
  • Xpert® MTB/XDR
  • Gulele, Addis Ababa, Ethiopia
  • +3 more
Jun 13, 2022

Promoting Engagement in Drug Resistant TB/HIV Care Continuum in

Completed
  • Patient Non-compliance
    • Durban, Kwa-Zulu Natal, South Africa
      King Dinuzulu Hospital
    Jul 19, 2022

    Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

    Active, not recruiting
    • Tuberculosis, Pulmonary
    • +5 more
    • Tbilisi, Georgia
    • +10 more
    Jan 26, 2022

    Pre-XDR-TB Trial in Seoul (BPaL regimen)

    Not yet recruiting
    • Pre-XDR-TB
    • BPaL regimen
    • Seoul, Songpa-gu, Korea, Republic of
      Asan Medical Center
    Jul 19, 2022

    Pre-Extensively Drug-Resistant Pulmonary TB, Treatment Intolerant Multidrug-Resistant Pulmonary TB, Non-responsive

    Recruiting
    • Pre-Extensively Drug-Resistant Pulmonary TB
    • +2 more
    • Agra, Uttarpradesh, India
      S N Medical College
    Nov 8, 2021

    Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

    Active, not recruiting
    • Tuberculosis
    • +4 more
    • Bedaquiline Oral Tablet
    • +7 more
    • Port Elizabeth, Eastern Cape, South Africa
    • +1 more
    Oct 20, 2022

    Adherence, Patient Trial in Durban (Wisepill device)

    Active, not recruiting
    • Adherence, Patient
    • Wisepill device
    • Durban, KwaZulu Natal, South Africa
      King Dinuzulu Hospital
    Jul 27, 2021

    TB-CAPT MTB/XDR Study

    Recruiting
    • Tuberculosis
    • +2 more
    • Xpert MTB/XDR
    • Cape Town, South Africa
    • +1 more
    May 17, 2021

    Pulmonary Tuberculosis Trial in Ysterplaat, Sydenham, Sandringham (Bedaquiline, PA-824, Linezolid)

    Completed
    • Pulmonary Tuberculosis
    • Ysterplaat, Cape Town, South Africa
    • +2 more
    Nov 19, 2020

    Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary Trial in Belarus, South

    Active, not recruiting
    • Tuberculosis, Multidrug-Resistant
    • +2 more
    • Minsk, Belarus
    • +6 more
    May 12, 2021

    Tuberculosis Trial in Tbilisi, Soweto (Ibuprofen, Standard of Care TB treatment)

    Completed
    • Tuberculosis
    • Tbilisi, Georgia
    • +1 more
    Dec 15, 2019

    Clinical Evaluation of tNGS for Diagnosis of DR-TB

    Active, not recruiting
    • Tuberculosis, Multidrug-Resistant
    • targeted Next Generation Sequencing (tNGS)
    • Tbilisi, Georgia
    • +2 more
    Jan 23, 2023

    Tuberculosis, Thoracic Surgery, Tuberculosis, Pulmonary Trial in Tbilisi (therapeutical surgery for TB)

    Active, not recruiting
    • Tuberculosis
    • +3 more
    • therapeutical surgery for TB
    • Tbilisi, Georgia
      National Center for Tuberculosis and Lung Diseases
    Sep 9, 2022

    A Multidrug-resistant and Extensively Drug- Resistant

    Unknown status
    • Tuberculosis
      • Strasbourg, France
        Service de Maladies Infectieuses et Tropicales
      Apr 29, 2019

      Bioneer Accupower Q-RFIA PCR Kit Clinical Evaluation

      Recruiting
      • Tuberculosis, Multidrug-Resistant
        • Nairobi, Kenya
        • +2 more
        Mar 16, 2022

        Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg

        Recruiting
        • Tuberculosis, Multidrug-Resistant
        • +2 more
        • Linezolid 600 mg
        • +7 more
        • Gaborone, South-East District, Botswana
        • +16 more
        Dec 13, 2022

        Xpert MTB/XDR Clinical Evaluation Trial

        Completed
        • Tuberculosis, Pulmonary
        • Tuberculosis, Multidrug-Resistant
        • Cepheid Gene Xpert MTB/XDR
        • Chisinau, Moldova, Republic of
          Institute of Pthisiopenumology
        May 17, 2021

        Drug-resistant Tuberculosis, HIV Coinfection, Cost-Benefit Analysis Trial in Cape Town (Targeted next-generation sequencing)

        Not yet recruiting
        • Drug-resistant Tuberculosis
        • +2 more
        • Targeted next-generation sequencing
        • Cape Town, South Africa
          South African National Health Laboratory Service
        Sep 23, 2022

        Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)

        Recruiting
        • Tuberculosis, Multidrug-Resistant
        • Dasmariñas, Philippines
        • +1 more
        Jun 21, 2022

        MDR-TB Trial in Shanghai (PRS Regimen V, MDR-TB Treatment Regimen(WHO))

        Recruiting
        • MDR-TB
        • PRS Regimen V
        • MDR-TB Treatment Regimen(WHO)
        • Shanghai, China
          Shanghai Pulmonary Hospital
        Aug 4, 2022

        Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculoses Trial in Belarus, South

        Recruiting
        • Multi-drug Resistant Tuberculosis
        • +2 more
        • Minsk, Belarus
        • +6 more
        May 12, 2021

        Multi Drug Resistant Tuberculosis, HIV Trial in Durban (Adherence support intevention)

        Not yet recruiting
        • Multi Drug Resistant Tuberculosis
        • HIV Infections
        • Adherence support intevention
        • Durban, KwaZulu-Natal, South Africa
          King DinuZulu Hospital
        Nov 21, 2022

        Tuberculosis, HIV Trial in United States (Efavirenz (EFV), TMC207)

        Completed
        • Tuberculosis
        • HIV
        • San Francisco, California
        • +4 more
        Oct 28, 2021

        Vitamin D Status and Adult Multidrug-resistant Pulmonary

        Completed
        • Multi-drug Resistant Tuberculosis
        • Serum Vitamin D
        • Mumbai, Maharashtra, India
          Foundations for Medical Research
        Feb 24, 2021

        TB Drugs and Bacterial Drug Resistance

        Completed
        • Tuberculosis
        • Non-Tuberculosis Mycobacteria
          • Bethesda, Maryland
          • +1 more
          Mar 25, 2022